APA (7th ed.) Citation

MS, S., AR, O., CA, L., JA, H., & AG, R. (2012). MLR-1023 is a potent and selective allosteric activator of Lyn kinase in vitro that improves glucose tolerance in vivo. The Journal of pharmacology and experimental therapeutics, 342(1), 15. https://doi.org/10.1124/jpet.112.192096

Chicago Style (17th ed.) Citation

MS, Saporito, Ochman AR, Lipinski CA, Handler JA, and Reaume AG. "MLR-1023 Is a Potent and Selective Allosteric Activator of Lyn Kinase in Vitro That Improves Glucose Tolerance in Vivo." The Journal of Pharmacology and Experimental Therapeutics 342, no. 1 (2012): 15. https://doi.org/10.1124/jpet.112.192096.

MLA (9th ed.) Citation

MS, Saporito, et al. "MLR-1023 Is a Potent and Selective Allosteric Activator of Lyn Kinase in Vitro That Improves Glucose Tolerance in Vivo." The Journal of Pharmacology and Experimental Therapeutics, vol. 342, no. 1, 2012, p. 15, https://doi.org/10.1124/jpet.112.192096.